Who Owns Vanda Pharmaceuticals Stock?
NASDAQ: VNDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 86.46%
- Held by insiders
- 6.78%
- Institutional holders
- 231
- Institutions 86.5%
- Insiders 6.8%
- Public and other 6.8%
Who owns Vanda Pharmaceuticals stock?
Institutional investors own about 86.5% of Vanda Pharmaceuticals's shares, spread across 231 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.78% of VNDA.
The largest institutional holders are Blackrock Inc. (12.66%), State Street Corporation (5.82%) and AQR Capital Management, LLC (5.78%). Together, the top 10 institutions control 48.6% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their VNDA positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VNDA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 7.65M | 12.66% | +5.2% |
| State Street Corporation | 3.52M | 5.82% | +16.6% |
| AQR Capital Management, LLC | 3.50M | 5.78% | +118.1% |
| Renaissance Technologies, LLC | 3.44M | 5.69% | -8.5% |
| Vanguard Capital Management LLC | 2.52M | 4.17% | +1.7% |
| AIGH Capital Management LLC | 2.04M | 3.38% | -25.7% |
| Acadian Asset Management. LLC | 1.92M | 3.17% | +6.8% |
| Dimensional Fund Advisors LP | 1.73M | 2.86% | -2.5% |
| Millennium Management Llc | 1.60M | 2.65% | -14.8% |
| Geode Capital Management, LLC | 1.48M | 2.45% | +2.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VNDA
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.42M | 4.00% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.76M | 2.91% |
| iShares Trust-iShares Russell 2000 ETF | 1.38M | 2.29% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 1.08M | 1.79% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 703.76K | 1.16% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 585.87K | 0.97% |
| iShares Trust-iShares Russell 2000 Value ETF | 510.98K | 0.85% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 489.96K | 0.81% |
| iShares Trust-iShares Biotechnology ETF | 425.25K | 0.70% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 333.67K | 0.55% |
Frequently asked questions
Who is the largest shareholder of Vanda Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of VNDA, owning 12.66% of shares outstanding (7.65M shares) as of its latest 13F filing.
What percentage of Vanda Pharmaceuticals is owned by institutions?
Institutions own about 86.5% of VNDA shares and 92.7% of the public float.
How much of Vanda Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 6.78% of VNDA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.